According to AABB Standards, what is the minimum number of platelets required in at least 90% of Apheresis Platelet units tested?

The AABB Standards outline the requirements for apheresis platelet units, focusing on the overall quality and functionality of the platelet products utilized in transfusion medicine. For apheresis platelets, the standard mandates that at least 90% of units tested should contain a minimum of 3.0 x 10^11 platelets. This requirement ensures that the platelet units provided to patients are sufficient for effective treatment of conditions like thrombocytopenia, where an adequate number of platelets is essential for hemostasis and to prevent bleeding complications.

The specified threshold of 3.0 x 10^11 platelets reflects the consensus in the medical community regarding what constitutes an effective therapeutic dose of platelets in an apheresis unit. This standard is designed to guarantee that patients receive platelet transfusions that reliably meet their clinical needs, thereby enhancing patient safety and treatment outcomes. Other values provided do not align with the consensus established in the current AABB Standards.